Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia

C C Blyth; H Darragh; A Whelan; J P O'Shea; M H Beaman; J S McCarthy

doi:10.1046/j.1445-5994.2001.00205.x

Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia

C C Blyth, H Darragh, A Whelan, J P O'Shea, M H Beaman, J S McCarthy

Research output: Contribution to journal › Article › peer-review

26 Citations (Scopus)

Abstract

BACKGROUND: While treatment guidelines have been developed to guide the management of Staphylococcus aureus bacteraemia, there is a need to validate these guidelines in different clinical settings and to relate the effect of compliance to clinical outcome.

AIMS: To assess the impact of adherence to treatment guidelines on clinical outcome and to explore the role of transoesophageal echocardiography (TOE) in risk stratification.

METHODS: We undertook a 2-year mixed retrospective and prospective study of all cases of S. aureus bacteraemia at Fremantle Hospital, documenting the clinical and microbiological features of each case, the results of echocardiography, adherence with published clinical guidelines and clinical outcome.

RESULTS: Failure to comply with guidelines was observed in 41% (38 of 93) of cases, the majority receiving abbreviated treatment. An increased rate of relapse was observed among patients who received inadequate therapy (5/38 vs 1/55; P= 0.04). Ten of 28 eligible patients underwent TOE and the test led to significant changes in management in two of those cases.

CONCLUSIONS: While non-adherence with clinical guidelines was associated with an increased risk of relapse, the role of TOE in risk stratification was limited by factors including cost, limited acceptance of the test and the need for prolonged therapy for other indications.

Original language	English
Pages (from-to)	224-32
Number of pages	9
Journal	Internal Medicine Journal
Volume	32
Issue number	5-6
DOIs	https://doi.org/10.1046/j.1445-5994.2001.00205.x
Publication status	Published - 31 May 2002

Access to Document

10.1046/j.1445-5994.2001.00205.x

Cite this

@article{20e88f4bef644fc7ba4a86e89bf2bdbc,

title = "Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia",

abstract = "BACKGROUND: While treatment guidelines have been developed to guide the management of Staphylococcus aureus bacteraemia, there is a need to validate these guidelines in different clinical settings and to relate the effect of compliance to clinical outcome.AIMS: To assess the impact of adherence to treatment guidelines on clinical outcome and to explore the role of transoesophageal echocardiography (TOE) in risk stratification.METHODS: We undertook a 2-year mixed retrospective and prospective study of all cases of S. aureus bacteraemia at Fremantle Hospital, documenting the clinical and microbiological features of each case, the results of echocardiography, adherence with published clinical guidelines and clinical outcome.RESULTS: Failure to comply with guidelines was observed in 41% (38 of 93) of cases, the majority receiving abbreviated treatment. An increased rate of relapse was observed among patients who received inadequate therapy (5/38 vs 1/55; P= 0.04). Ten of 28 eligible patients underwent TOE and the test led to significant changes in management in two of those cases.CONCLUSIONS: While non-adherence with clinical guidelines was associated with an increased risk of relapse, the role of TOE in risk stratification was limited by factors including cost, limited acceptance of the test and the need for prolonged therapy for other indications.",

keywords = "Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Bacteremia/diagnosis, Child, Child, Preschool, Echocardiography, Transesophageal, Endocarditis, Bacterial/diagnostic imaging, Female, Humans, Male, Middle Aged, Practice Guidelines as Topic/standards, Prospective Studies, Retrospective Studies, Staphylococcal Infections/diagnosis, Staphylococcus aureus/isolation & purification, Treatment Outcome",

author = "Blyth, {C C} and H Darragh and A Whelan and O'Shea, {J P} and Beaman, {M H} and McCarthy, {J S}",

year = "2002",

month = may,

day = "31",

doi = "10.1046/j.1445-5994.2001.00205.x",

language = "English",

volume = "32",

pages = "224--32",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley & Sons",

number = "5-6",

}

TY - JOUR

T1 - Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia

AU - Blyth, C C

AU - Darragh, H

AU - Whelan, A

AU - O'Shea, J P

AU - Beaman, M H

AU - McCarthy, J S

PY - 2002/5/31

Y1 - 2002/5/31

N2 - BACKGROUND: While treatment guidelines have been developed to guide the management of Staphylococcus aureus bacteraemia, there is a need to validate these guidelines in different clinical settings and to relate the effect of compliance to clinical outcome.AIMS: To assess the impact of adherence to treatment guidelines on clinical outcome and to explore the role of transoesophageal echocardiography (TOE) in risk stratification.METHODS: We undertook a 2-year mixed retrospective and prospective study of all cases of S. aureus bacteraemia at Fremantle Hospital, documenting the clinical and microbiological features of each case, the results of echocardiography, adherence with published clinical guidelines and clinical outcome.RESULTS: Failure to comply with guidelines was observed in 41% (38 of 93) of cases, the majority receiving abbreviated treatment. An increased rate of relapse was observed among patients who received inadequate therapy (5/38 vs 1/55; P= 0.04). Ten of 28 eligible patients underwent TOE and the test led to significant changes in management in two of those cases.CONCLUSIONS: While non-adherence with clinical guidelines was associated with an increased risk of relapse, the role of TOE in risk stratification was limited by factors including cost, limited acceptance of the test and the need for prolonged therapy for other indications.

AB - BACKGROUND: While treatment guidelines have been developed to guide the management of Staphylococcus aureus bacteraemia, there is a need to validate these guidelines in different clinical settings and to relate the effect of compliance to clinical outcome.AIMS: To assess the impact of adherence to treatment guidelines on clinical outcome and to explore the role of transoesophageal echocardiography (TOE) in risk stratification.METHODS: We undertook a 2-year mixed retrospective and prospective study of all cases of S. aureus bacteraemia at Fremantle Hospital, documenting the clinical and microbiological features of each case, the results of echocardiography, adherence with published clinical guidelines and clinical outcome.RESULTS: Failure to comply with guidelines was observed in 41% (38 of 93) of cases, the majority receiving abbreviated treatment. An increased rate of relapse was observed among patients who received inadequate therapy (5/38 vs 1/55; P= 0.04). Ten of 28 eligible patients underwent TOE and the test led to significant changes in management in two of those cases.CONCLUSIONS: While non-adherence with clinical guidelines was associated with an increased risk of relapse, the role of TOE in risk stratification was limited by factors including cost, limited acceptance of the test and the need for prolonged therapy for other indications.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Algorithms

KW - Bacteremia/diagnosis

KW - Child

KW - Child, Preschool

KW - Echocardiography, Transesophageal

KW - Endocarditis, Bacterial/diagnostic imaging

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Practice Guidelines as Topic/standards

KW - Prospective Studies

KW - Retrospective Studies

KW - Staphylococcal Infections/diagnosis

KW - Staphylococcus aureus/isolation & purification

KW - Treatment Outcome

U2 - 10.1046/j.1445-5994.2001.00205.x

DO - 10.1046/j.1445-5994.2001.00205.x

M3 - Article

C2 - 12036220

SN - 1444-0903

VL - 32

SP - 224

EP - 232

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 5-6

ER -

Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia

Abstract

Access to Document

Fingerprint

Cite this